亚太地区药品合同销售组织市场预测至 2030 年 - 区域分析 - 按服务(商业服务和非商业服务)、模块(联合模块和专用模块)、治疗领域(心血管疾病、肿瘤学、代谢性疾病、神经病学、骨科疾病) 、传染病等)和最终用户(生物制药公司和制药公司)

BMIRE00030019 | Pages: 88 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
亚太地区药品合同销售组织市场预计将从 2022 年的 17.0748 亿美元增长到 2030 年的 36.4688 亿美元。预计 2022 年至 2030 年复合年增长率为 10.0%。 远程医疗和远程细节驱动器的使用不断增加亚太地区药品合同销售组织市场 远程医疗和远程详细咨询的日益普及为药品合同销售组织 (CSO) 市场带来了新的机遇。数字健康技术的变革性影响重新定义了医患互动,并彻底改变了药品销售的动态。远程医疗具有促进虚拟咨询和参与的能力,为公民社会组织的适应和创新创造了肥沃的土壤。远程详细信息涉及使用数字渠道传达产品信息并吸引医疗保健专业人员,成为公民社会组织扩大影响范围的战略途径。这一战略变化凸显了制药行业为应对市场复杂性而采取的积极主动的方法。通过与公民社会组织合作,这些企业可以接触到专业销售人员,利用外部专业知识来提高市场渗透率并提高销售效率。通过这种协作模式,制药公司可以简化其运营并专注于研发等关键能力,同时利用公民社会组织的特定知识来提高其产品的适销性。制药公司和民间社会组织之间不断加强的合作表明了对适应的奉献精神以及对竞争激烈的制药行业发展动态的深刻把握。它还显示了对资源优化的细致入微的理解。这种互惠互利的合作伙伴关系使收入最大化成为可能,并从战略上将制药公司置于适应性和针对性强的市场战略对于长期成功至关重要的市场中。亚太地区药品合同销售组织市场概述 近年来,由于对具有成本效益的销售和营销解决方案的需求不断增加,亚太地区药品合同销售组织市场经历了显着增长。尽管这些国家对医疗保健产品的需求很大,但制药公司在进入中国、印度和日本等国家的多元化和偏远市场方面面临着挑战。通过将销售和营销职能外包给公民社会组织,公司可以从专业团队的专业知识中受益,而无需大量的基础设施和人员投资。此外,亚太地区慢性病的增加和人口老龄化的加剧也促进了药品合同销售组织市场的扩大。数字技术的可用性和采用率不断提高,以及对大量数据源的轻松访问,使制药 CSO 能够收集和分析实时数据,从而帮助其客户使用可行的见解。 2023年4月,赛诺菲中国采用了可扩展的商业无所不在的CRM解决方案,该解决方案将适应其不断发展、动态的业务模式,从而加速数字化转型,并使公司能够继续致力于创新。 Omnipresence CRM 使用先进的分析、数据源和机器学习来生成见解、支持更好的决策,并为商业团队创造新的机会,以提高敏捷性来加速取得成果。亚太地区药品合同销售组织市场收入和预测到 2030 年(百万美元) 亚太地区药品合同销售组织市场细分 亚太地区药品合同销售组织市场细分为服务、模块、治疗领域、最终用户和国家/地区。根据服务,亚太地区药品合同销售组织市场分为商业服务和非商业服务。 2022年,商业服务细分市场在亚太药品合同销售组织市场中占据较大份额。根据模块,亚太药品合同销售组织市场分为联合模块和专用模块。到2022年,联合模块细分市场在亚太药品合同销售组织市场中占据较大份额。根据治疗领域,亚太药品合同销售组织市场细分为心血管疾病、肿瘤、代谢性疾病、神经病学、骨科疾病、传染性疾病疾病,以及其他。 2022年,肿瘤学领域在亚太药品合同销售组织市场中占据最大份额。根据最终用户,亚太药品合同销售组织市场分为生物制药公司和制药公司。到 2022 年,制药公司细分市场在亚太地区药品合同销售组织市场中占据较大份额。按国家/地区划分,亚太地区药品合同销售组织市场分为中国、日本、印度、澳大利亚、韩国和其他地区。亚太地区。 2022 年,中国在亚太地区药品合同销售组织市场占据主导地位。Aenova Holding GmbH、CMIC Holdings Co Ltd、EPS Holdings Inc、IQVIA Holdings Inc、Mednext Pharmaceuticals Pvt Ltd、辉瑞 Inc 和 Syneos Health Inc 是在亚太地区运营的一些领先公司。亚太地区药品合同销售组织市场。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Asia Pacific Market Analysis

6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Asia Pacific

11.1.1.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 China

11.1.1.2.1 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Japan

11.1.1.3.1 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 India

11.1.1.4.1 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.5 Australia

11.1.1.5.1 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.5.2 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.5.3 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.5.4 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.5.5 Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.6 South Korea

11.1.1.6.1 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.6.2 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.6.3 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.6.4 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.6.5 South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.7 Rest of Asia Pacific

11.1.1.7.1 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.7.2 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.7.3 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.7.4 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.7.5 Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 EPS Holdings Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 IQVIA Holdings Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Syneos Health Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Mednext Pharmaceuticals Pvt Ltd

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Aenova Holding GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.7 Pfizer Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

?

List of Tables

Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market

?

List of Figures

Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. Asia Pacific - PEST Analysis

Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. CMIC Holdings Co Ltd

3. EPS Holdings Inc

4. IQVIA Holdings Inc

5. Mednext Pharmaceuticals Pvt Ltd

6. Pfizer Inc

7. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440